Engineers turn the body’s goo into new glue
They combined a blend of slimy and sticky proteins to produce a fast-acting, bacteria-blocking, waterproof adhesive for use in biomedical applications.
They combined a blend of slimy and sticky proteins to produce a fast-acting, bacteria-blocking, waterproof adhesive for use in biomedical applications.
The nitrogen product developed by the company, which was co-founded by Professor Chris Voigt, is being used across millions of acres of American farmland.
A professor of genetics, toxicology, and biological engineering, Thilly pushed himself and his students to develop solutions to real-world problems.
Four professors and an additional alumnus honored with nation’s highest awards for scientists and engineers; Moderna, with deep MIT roots, also recognized.
A new study of the microbiome finds intestinal bacterial interact much less often with viruses that trigger immunity updates than bacteria in the lab.
Inviting recent postdocs and sabbatical-eligible faculty to pursue their research at MIT, new programs envision eventually supporting 16 Israeli scholars on campus annually.
Five MIT faculty and staff, along with 19 additional alumni, are honored for electrical engineering and computer science advances.
Junior Katie Spivakovsky describes her path through New Engineering Education Transformation to biomedical research and beyond.
Ten objects on display in the Koch Institute Public Galleries offer uncommon insights into the people and progress of MIT's cancer research community.
Using high-powered lasers, this new method could help biologists study the body’s immune responses and develop new medicines.
By sidestepping the need for costly interventions, a new method could potentially reveal gene regulatory programs, paving the way for targeted treatments.
The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.
MIT engineers’ new model could help researchers glean insights from genomic data and other huge datasets.
The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors.
SMART researchers find mesenchymal stromal cells are an attractive alternative to current costly, time-intensive treatments.